🇺🇸 HyQvia in United States

2,441 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Headache — 367 reports (15.03%)
  2. Sinusitis — 336 reports (13.76%)
  3. Fatigue — 297 reports (12.17%)
  4. Infusion Site Erythema — 214 reports (8.77%)
  5. Infusion Site Pain — 212 reports (8.68%)
  6. Nausea — 209 reports (8.56%)
  7. Malaise — 206 reports (8.44%)
  8. Infusion Site Swelling — 204 reports (8.36%)
  9. Pain — 198 reports (8.11%)
  10. Pyrexia — 198 reports (8.11%)

Source database →

HyQvia in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is HyQvia approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for HyQvia in United States?

Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.